Published in Cell Immunol on March 01, 1979
Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.49
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun (1986) 1.26
Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun (1979) 1.25
Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci U S A (1980) 1.16
Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun (1983) 1.04
Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun (1981) 1.02
Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun (1980) 0.97
Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein. Infect Immun (1984) 0.84
Membrane alteration responsible for the induction of gamma interferon. Infect Immun (1982) 0.82
Recombinant mouse interferon-gamma regulation of antibody production. Infect Immun (1983) 0.81
Transfer of interferon-induced viral resistance from human leukocytes to other cell types. Infect Immun (1980) 0.81
Streptococcus pneumoniae cocultured with fibroblasts enhances both interferon production and cytotoxic activity by lymphocytes. Infect Immun (1985) 0.81
Transformed and normal cell surface glycoproteins that induce interferon production by nonsensitized lymphocytes. Infect Immun (1983) 0.75
Microassay for Sindbis virus and interferon activity. J Clin Microbiol (1983) 0.75
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
Corticotropin-releasing activity of monokines. Science (1985) 2.24
CFTR chloride channel regulation by an interdomain interaction. Science (1999) 2.09
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99
Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85
Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med (1982) 1.81
Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem Biophys Res Commun (1984) 1.77
Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci U S A (1985) 1.75
Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature (1986) 1.65
Acute hemorrhagic conjunctivitis. Am Fam Physician (1992) 1.62
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.49
Cloning and direct sequencing from lambda cDNA libraries using the polymerase chain reaction: suppressin and the vasopressin receptor as models. Neth J Med (1991) 1.49
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci U S A (1982) 1.44
Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol (2007) 1.41
Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. Science (1982) 1.35
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
The immune system as a sensory organ. J Immunol (1984) 1.30
Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. Biochem Biophys Res Commun (1985) 1.27
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23
Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol (1976) 1.22
In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J Clin Endocrinol Metab (1987) 1.17
Calcium influx factor is synthesized by yeast and mammalian cells depleted of organellar calcium stores. Proc Natl Acad Sci U S A (1999) 1.17
Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci U S A (1980) 1.16
Binding of peptides that are specified by complementary RNAs. Biochem J (1986) 1.16
Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc Natl Acad Sci U S A (1986) 1.15
Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. Infect Immun (1983) 1.13
Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13
Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin. Methods Enzymol (1981) 1.12
Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev (1987) 1.12
Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci U S A (1986) 1.12
Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12
Common pathways of interferon and hormonal action. Nature (1980) 1.10
Enhanced detection of Western equine encephalitis virus plaque variants in crowded cultures and plaque progeny--potential use in genetic studies. Appl Microbiol (1974) 1.08
Human immune interferon: induction in lymphoid cells by a calcium ionophore. Infect Immun (1980) 1.07
Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol (1984) 1.05
Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun (1983) 1.04
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol (1989) 1.04
Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc Natl Acad Sci U S A (1988) 1.04
Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol (1978) 1.04
Generation of a soluble IFN-gamma inducer by oxidation of galactose residues on macrophages. Cell Immunol (1985) 1.03
Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol (1995) 1.03
Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci U S A (1983) 1.03
Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol (1985) 1.02
Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun (1981) 1.02
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol (1986) 1.00
Cell-produced viral inhibitor: possible mechanism of action and chemical composition. Infect Immun (1981) 0.99
Molecular characterization of a corticotropin (ACTH) receptor. Mol Cell Endocrinol (1986) 0.98
Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea. Invest Ophthalmol Vis Sci (2001) 0.98
An analysis of the binding of repressor protein ModE to modABCD (molybdate transport) operator/promoter DNA of Escherichia coli. J Biol Chem (1999) 0.98
Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis (1979) 0.97
Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry. J Biol Chem (1998) 0.97
Early-appearing antiviral activity in human tears during a case of picornavirus epidemic conjunctivitis. J Infect Dis (1979) 0.97
Immune-type interferon-induced transfer of viral resistance. J Immunol (1979) 0.97
Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science (1988) 0.97
Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol (1989) 0.97
Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun (1980) 0.97
Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J (1988) 0.96
Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem Biophys Res Commun (1981) 0.96
Retinoic acid and the restoration of anchorage dependent growth to transformed mammalian cells. Exp Cell Res (1978) 0.96
Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J Immunol (1987) 0.96
Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun (1985) 0.94
Vitamin A-induced density-dependent inhibition of L-cell proliferation. J Natl Cancer Inst (1977) 0.94
Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide. Proc Natl Acad Sci U S A (1990) 0.94
Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microb Pathog (1987) 0.93
Neuroendocrine peptide hormones and their receptors in the immune system. Production, processing and action. J Neuroimmunol (1985) 0.93
Mechanisms of interferon induced transfer of viral resistance between animal cells. J Gen Virol (1979) 0.93
Induction of interferon by bacteria, protozoa, and viruses: defensive role. Tex Rep Biol Med (1983) 0.92
A complete regulatory loop between the immune and neuroendocrine systems. Fed Proc (1985) 0.92
Virus yield-reduction assay for interferon by titration of infectious virus. Methods Enzymol (1981) 0.92
Interferon and adrenocorticotropic hormone induction of steroidogenesis, melanogenesis and antiviral activity. Arch Virol (1981) 0.92
Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory. J Immunol (1987) 0.92
Production of interferon gamma messenger RNA by cells of non-immune origin. Cytokine (1995) 0.91
Cellular requirements for thyrotropin enhancement of in vitro antibody production. J Immunol (1986) 0.91
Retinoic acid (vitamin A acid) induced transcriptional control of interferon production. Proc Natl Acad Sci U S A (1977) 0.91
De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem (2000) 0.91
Staphylococcus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells. J Immunol (1983) 0.90